EMA Backs Oral Suspension for Malignant Brain Tumors

21 Oct 2026 0 comments

European regulators recommend an oral suspension of an established cancer drug for adult and pediatric patients with recurrent or newly diagnosed malignant brain tumors.
Medscape News Europe

Source: Medscape Neurology Published 21 Oct 2026 Imported 21 Oct 2026 Relevancy: Not reviewed

Read the article

Comments

No comments yet.

Unrestricted

All comments are reviewed before being published. Most comments are approved unless they are clearly inappropriate or unsafe.

Comments

Leave a comment